Antares Pharma, Inc. (ATRS)

EBITDA Margin

-4.89%

Quarterly · Period ending:

ATRS logo

ATRS EBITDA Margin

Latest reported-4.89%
ATRS Quarterly EBITDA Margin (-125.00% → -4.89%)
High-resolution chart · PNG

ATRS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. EBITDA Margin — Quarterly
Period endingEBITDA Margin
-4.8921%
94.8984%
18.5035%
16.9394%
14.8255%
15.8158%
15.9388%
11.4377%
-2.1917%
16.9534%
7.9228%
-3.0036%
-18.0366%
41.2624%
-3.6994%
-23.0405%
-39.0302%
-17.8214%
-28.4199%
-17.6066%
-35.3301%
-27.5505%
-41.8498%
-45.6611%
-58.7929%
-51.2659%
-48.1449%
-7.7409%
-76.774%
-115.4102%
-103.7514%
-139.3866%
-164.7353%
-113.069%
-113.1391%
-85.9632%
-73.6234%
-90.1397%
-60.3504%
-61.4079%
-0.41%
-1.9758%
-32.0147%
-42.8395%
-37.5427%
-37.9788%
-50.6612%
-49.3808%
-46.4735%
-91.1207%
-125.5325%
-122.2482%
-122.6109%
-149.3819%
-235.7392%
-224.971%
-302.0356%
-48.0814%
-197.3601%
-104.9928%
-10.3854%
-64.2822%
-236.5566%
-271.5558%
-343.3773%
-245.4609%
-417.6957%
-438.7724%
-391.0661%
-309.3354%
-356.2327%
-217.5825%
-219.3225%
-269.2573%
-2,215.6154%
-380.0996%
-279.8471%
-243.4501%
-287.0612%
-151.3521%
-286.003%
-276.4861%
-306.313%
-120.9612%
-237.3611%
-705.2929%
-226.627%
-105.7366%
-151.4547%
-69.334%
-240%
-183.3333%
-25%
-476.7425%
-200%
-150%
-100%
-11.972%
-166.6667%
-88.8889%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.